William Blair Investment Management LLC raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 7.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 370,707 shares of the company’s stock after acquiring an additional 24,848 shares during the quarter. William Blair Investment Management LLC’s holdings in U.S. Physical Therapy were worth $28,949,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its stake in U.S. Physical Therapy by 106.9% in the third quarter. JPMorgan Chase & Co. now owns 109,837 shares of the company’s stock valued at $9,331,000 after buying an additional 56,752 shares during the period. Bahl & Gaynor Inc. raised its position in shares of U.S. Physical Therapy by 47.6% during the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after purchasing an additional 153,054 shares during the period. American Century Companies Inc. acquired a new position in shares of U.S. Physical Therapy during the third quarter worth approximately $21,940,000. M&T Bank Corp raised its position in shares of U.S. Physical Therapy by 172.7% during the fourth quarter. M&T Bank Corp now owns 28,676 shares of the company’s stock worth $2,239,000 after purchasing an additional 18,159 shares during the period. Finally, Public Sector Pension Investment Board raised its position in shares of U.S. Physical Therapy by 14.5% during the third quarter. Public Sector Pension Investment Board now owns 59,355 shares of the company’s stock worth $5,042,000 after purchasing an additional 7,535 shares during the period.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on USPH shares. Barrington Research lowered their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Jefferies Financial Group raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Zacks Research lowered U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 28th. Finally, Citizens Jmp lowered their target price on U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $97.50.
Insiders Place Their Bets
In related news, COO Graham D. Reeve sold 662 shares of the stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total value of $52,205.32. Following the completion of the sale, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This represents a 2.15% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Richard Binstein sold 3,000 shares of the stock in a transaction on Friday, March 6th. The shares were sold at an average price of $81.64, for a total value of $244,920.00. Following the completion of the sale, the executive vice president directly owned 24,867 shares of the company’s stock, valued at $2,030,141.88. The trade was a 10.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.40% of the company’s stock.
U.S. Physical Therapy Trading Up 0.1%
NYSE USPH opened at $62.02 on Monday. The firm has a market capitalization of $943.96 million, a P/E ratio of 124.04, a PEG ratio of 1.71 and a beta of 1.21. The business has a fifty day simple moving average of $71.90 and a 200 day simple moving average of $77.43. U.S. Physical Therapy, Inc. has a 12 month low of $58.19 and a 12 month high of $93.50. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). The company had revenue of $198.29 million during the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.48 earnings per share. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is presently 368.00%.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
